FDA Inspection 1119010 — Florida Institute for Reproductive Medicine

Florida Institute for Reproductive Medicine — FEI 3003926648

The FDA completed an inspection of Florida Institute for Reproductive Medicine on January 6, 2020 in Jacksonville, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 6, 2020
Fiscal Year
2020
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Jacksonville, FL (United States)